Other languages LadRx Corporation

Equities

LADX

US2328287071

Market Closed - OTC Markets Other stock markets 11:43:28 2024-06-21 EDT			5-day change	1st Jan Change
2.24 ^USD	+5.16%		-18.84%	+72.31%

06-04	LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License	CI
05-15	LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License	06-03
LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-27
LadRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14
LadRx Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
LadRx Corporation has filed an IPO in the amount of $24 million.	23-04-14
LadRx Highlights Patent Issued for Its LADR Technology	23-03-27
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20
LadRx Corporation Auditor Raises 'Going Concern' Doubt	23-03-19
LadRx Announces Review of Strategic Alternatives	23-03-15
LadRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10
LadRx Corporation will Change its Ticker to LADX from CYTR	22-10-06
LadRx Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11
CytRx Corporation Appoints Cary J. Claiborne to its Board of Directors and as Member of Audit Committee and Chairperson of Compensation Committee	22-08-09
CytRx Corporation Announces Director Changes	22-06-02
CytRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12
CytRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-23
CytRx Corporation Auditor Raises 'Going Concern' Doubt	22-03-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages LadRx Corporation

Equities

LADX

US2328287071

Other languages

Filters